Health care company focused on renal and other chronic conditions
Provider Relief Fund, phase 4 reconsideration; S. 3799, PREVENT Pandemics Act; Issues related to the Public Health Emergency; H.R. 2617, Consolidated Appropriations Act, 2023 - increasing Medicare Physician Fee Schedule payments and extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31, 2024 Issues related to End Stage Renal Disease and Chronic Kidney Disease; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-1768-F); H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
ELIZABETH MACDONALD BARNETT ELIZABETH MACDONALD BARNETT